Your browser doesn't support javascript.
loading
Modified ethoxyethyl cyanoacrylate for therapeutic embolization of arteriovenous malformation.
Tseng, Y C; Hyon, S H; Ikada, Y; Taki, W; Uno, A; Yonekawa, Y.
Afiliación
  • Tseng YC; Research Center for Medical Polymers and Biomaterials, Kyoto University, Japan.
J Biomed Mater Res ; 24(1): 65-77, 1990 Jan.
Article en En | MEDLINE | ID: mdl-2154499
ABSTRACT
Aiming at alleviating the problems of using 2-cyanoacrylates as a material for therapeutic embolization, this experiment made some physical modifications by mixing contrast media. It was found that the physicochemical properties of 2-cyanoacrylates can be altered by changing the concentration and the composition of the contrast media added. A 50 wt% cyanoacrylate-50 wt% contrast medium mixture has enough radiopacity for the practical requirement for embolization. A mixture of 50 wt% (ethoxyethyl cyanoacrylate-5 wt% lactide/epsilon-caprolactone copolymer), 25 wt% lipiodol and 25 wt% tetrafluorodibromoethane provides a viscosity of 13.8 cP, a bonding strength of 14.9 kg/cm2, a set time of 6 s, and a spreading in canine blood of 33 mm. It was concluded that the mixture is much more satisfactory than the conventional cyanoacrylates as an embolus material in vitro. The results obtained by in vivo experiments and clinical trials so far suggest that the mixture is very promising as a material for embolization.
Asunto(s)
Buscar en Google
Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas Asunto principal: Malformaciones Arteriovenosas / Cianoacrilatos / Embolización Terapéutica Idioma: En Revista: J Biomed Mater Res Año: 1990 Tipo del documento: Article País de afiliación: Japón
Buscar en Google
Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas Asunto principal: Malformaciones Arteriovenosas / Cianoacrilatos / Embolización Terapéutica Idioma: En Revista: J Biomed Mater Res Año: 1990 Tipo del documento: Article País de afiliación: Japón